Axol Bioscience specialize in the supply of human cell culture systems and custom services for disease modeling and drug discovery. Our expertise includes induced pluripotent stem cell (iPSC) generation, CRISPR-Cas9 gene editing, iPSC differentiation and custom cell and tissue sourcing.

We offer a variety of functionally validated human primary cells and human iPSC-derived cells from both healthy and patient donors alongside culture media and reagents that are tailored to support the optimal growth and maturation of our cells. This enables you to carry out your project in a physiologically relevant system that is not only reliable and easy to use but produces consistent results for robust replication studies. Our team is passionate about great science, delivering superb customer service and support and innovating future products to help customers advance their research faster. At Axol, innovation, quality and customer service are key.





We offer a variety of human iPSC-derived neural cells for neurotoxicity studies and iPSC-derived cardiomyocytes for cardiotoxicity screening. Our toxicology range also comprises a number of human primary cells including human hepatocytes validated for hepatoxicity and genotoxicity assays, liver sinusoidal endothelial cells which are ideal for co-culture, renal cells suitable for nephrotoxicity studies and airway epithelial cells. We also offer tailored media and reagents to support the optimal culture and maintenance of all our cells. Our custom services can help you source specific donor cells, carry out footprint-free reprograming to generate iPSCs, conduct gene editing and/or use our highly validated differentiation protocols to generate your cell type of interest.


regenerative medicine tools